Metabolic syndrome induced by anticancer treatment in childhood cancer survivors
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
The number of childhood cancer survivors is increasing as survival rates improve. However, complications after treatment have not received much attention, particularly metabolic syndrome. Metabolic syndrome comprises central obesity, dyslipidemia, hypertension, and insulin resistance, and cancer survivors have higher risks of cardiovascular events compared with the general population. The mechanism by which cancer treatment induces metabolic syndrome is unclear. However, its pathophysiology can be categorized based on the cancer treatment type administered. Brain surgery or radiotherapy may induce metabolic syndrome by damaging the hypothalamic-pituitary axis, which may induce pituitary hormone deficiencies. Local therapy administered to particular endocrine organs directly damages the organs and causes hormone deficiencies, which induce obesity and dyslipidemia leading to metabolic syndrome. Chemotherapeutic agents interfere with cell generation and growth, damage the vascular endothelial cells, and increase the cardiovascular risk. Moreover, chemotherapeutic agents induce oxidative stress, which also induces metabolic syndrome. Physical inactivity caused by cancer treatment or the cancer itself, dietary restrictions, and the frequent use of antibiotics may also be risk factors for metabolic syndrome. Since childhood cancer survivors with metabolic syndrome have higher risks of cardiovascular events at an earlier age, early interventions should be considered. The optimal timing of interventions and drug use has not been established, but lifestyle modifications and exercise interventions that begin during cancer treatment might be beneficial and tailored education and interventions that account for individual patients’ circumstances are needed. This review evaluates the recent literature that describes metabolic syndrome in cancer survivors, with a focus on its pathophysiology.
Abstract
The number of childhood cancer survivors is increasing as survival rates improve. However, complications after treatment have not received much attention, particularly metabolic syndrome. Metabolic syndrome comprises central obesity, dyslipidemia, hypertension, and insulin resistance, and cancer survivors have higher risks of cardiovascular events compared with the general population. The mechanism by which cancer treatment induces metabolic syndrome is unclear. However, its pathophysiology can be categorized based on the cancer treatment type administered. Brain surgery or radiotherapy may induce metabolic syndrome by damaging the hypothalamic-pituitary axis, which may induce pituitary hormone deficiencies. Local therapy administered to particular endocrine organs directly damages the organs and causes hormone deficiencies, which induce obesity and dyslipidemia leading to metabolic syndrome. Chemotherapeutic agents interfere with cell generation and growth, damage the vascular endothelial cells, and increase the cardiovascular risk. Moreover, chemotherapeutic agents induce oxidative stress, which also induces metabolic syndrome. Physical inactivity caused by cancer treatment or the cancer itself, dietary restrictions, and the frequent use of antibiotics may also be risk factors for metabolic syndrome. Since childhood cancer survivors with metabolic syndrome have higher risks of cardiovascular events at an earlier age, early interventions should be considered. The optimal timing of interventions and drug use has not been established, but lifestyle modifications and exercise interventions that begin during cancer treatment might be beneficial and tailored education and interventions that account for individual patients’ circumstances are needed. This review evaluates the recent literature that describes metabolic syndrome in cancer survivors, with a focus on its pathophysiology.
참고문헌 (43)
- 박현진, "Incidence and Survival of Childhood Cancer in Korea", Cancer Research and Treatment, 48(3), pp.869~882 (2016), 대한암학회
- de Haas EC, "The metabolic syndrome in cancer survivors", Lancet Oncol, 11, pp.193~203 (2010)
- Talvensaari KK, "Longterm survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome", J Clin Endocrinol Metab, 81, pp.3051~3055 (1996)
- Casco S, "Development of metabolic syndrome associated to cancer therapy: review", Horm Cancer, 7, pp.289~295 (2016)
- Gibson TM, "Obesity and metabolic syndrome among adult survivors of childhood leukemia", Curr Treat Options Oncol, 17, pp.17~ (2016)
- 임한혁, "Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency", Korean Journal of Pediatrics, 53(10), pp.892~897 (2010), 대한소아과학회
- 손영배, "The metabolic syndrome and body composition in childhood cancer survivors", Korean Journal of Pediatrics, 54(6), pp.253~259 (2011), 대한소아과학회
- Kyong-Won Bang, "Evaluation of changes in random blood glucose and body mass index during and after completion of chemotherapy in children with acute lymphoblastic leukemia", Korean Journal of Pediatrics, 55(4), pp.121~127 (2012), 대한소아과학회
- 신혜경, "소아암 생존자에서 대사증후군 구성 요소의 유병률", Clinical Pediatric Hematology-Oncology, 21(1), pp.23~28 (2014), 대한소아혈액종양학회
- Odame I, "Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia", Arch Dis Child, 71, pp.147~149 (1994)
- Didi M, "High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood", J Pediatr, 127, pp.63~67 (1995)
- Neville KA, "Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors", J Clin Endocrinol Metab, 91, pp.4401~4407 (2006)
- Malhotra J, "Atherogenic low density lipoprotein phenotype in long-term survivors of childhood acute lymphoblastic leukemia", J Lipid Res, 53, pp.2747~2754 (2012)
- Nottage KA, "Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort", Br J Haematol, 165, pp.364~374 (2014)
- Rosen GP, "Metabolic syndrome in pediatric cancer survivors: a mechanistic review", Pediatr Blood Cancer, 60, pp.1922~1928 (2013)
- Barbosa-Cortés L, "Del Carmen Rodríguez-Zepeda M, Rivera-Márquez H, et al. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country", BMC Cancer, 17, pp.125~ (2017)
- Morel S, "Lipid and lipoprotein abnormalities in acute lymphoblastic leukemia survivors", J Lipid Res, 58, pp.982~993 (2017)
- Armenian SH, "Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease", Blood, 120, pp.4505~4512 (2012)
- Ross JA, "Genetic variation in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study", J Clin Oncol, 22, pp.3558~3562 (2004)
- Wilson CL, "Genetic and clinical factors associated with obesity among adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort", Cancer, 121, pp.2262~2270 (2015)
- Marcoux S, "The PETALE study: Late adverse effects and biomarkers in childhood acute lymphoblastic leukemia survivors", Pediatr Blood Cancer, 64 (2017)
- Kate A, "Incidence of metabolic syndrome in breast cancer survivors on adjuvant hormonal therapy", J Pharmacol Pharmacother, 7, pp.28~30 (2016)
- Darzy KH, "Hypopituitarism following radiotherapy", Pituitary, 12, pp.40~50 (2009)
- Westerink NL, "Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle", Crit Rev Oncol Hematol, 108, pp.128~136 (2016)
- Meinardi MT, "Cardiovascular morbidity in long-term survivors of metastatic testicular cancer", J Clin Oncol, 18, pp.1725~1732 (2000)
- Sheean P, "Examining the prevalence of metabolic syndrome among overweight", obese African-American breast cancer survivors vs. matched non-cancer controls, 2017, pp.11, 102~110
- Roos A, "Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects", J Clin Endocrinol Metab, 92, pp.491~496 (2007)
- Tell R, "Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer", Int J Radiat Oncol Biol Phys, 60, pp.395~400 (2004)
- Sanders JE, "Thyroid function following hematopoietic cell transplantation in children: 30 years' experience", Blood, 113, pp.306~308 (2009)
- Mohapatra S, "Is there an increased risk of metabolic syndrome among childhood acute lymphoblastic leukemia survivors? A developing country experience", Pediatr Hematol Oncol, 33, pp.136~149 (2016)
- Green DM, "Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study", J Clin Oncol, 27, pp.2374~2381 (2009)
- Mayer EI, "Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood", Horm Res, 53, pp.193~199 (2000)
- Brennan BM, "Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity", Clin Endocrinol (Oxf), 50, pp.163~169 (1999)
- Ness KK, "Physical performance limitations in the Childhood Cancer Survivor Study cohort", J Clin Oncol, 27, pp.2382~2389 (2009)
- Grundy SM, "Diagnosis and management of the metabolic syndrome: an American Heart Association", National Heart, Lung, and Blood Institute Scientific Statement, 2005, pp.112, 2735~2752
- Rugbjerg K, "Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943-2009", J Natl Cancer Inst, 106, pp.dju110~ (2014)
- Bao PP, "Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study", Cancer Causes Control, 24, pp.1747~1756 (2013)
- Grote S, "Cardiometabolic Health Among Cancer Survivors: A 13-week pilot study of a combined aerobic and resistance training program", Oncol Nurs Forum, 43, pp.306~315 (2016)
- Tonorezos ES, "Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia", Cancer Causes Control, 24, pp.313~321 (2013)
- Smith WA, "Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study", Cancer, 120, pp.2742~2750 (2014)
- Cohen JE, "Nutritional interventions for survivors of childhood cancer", Cochrane Database Syst Rev, (8), pp.CD009678~ (2016)
- Follin C, "Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia", J Clin Endocrinol Metab, 91, pp.1872~1875 (2006)
- Woodmansee WW, "Incidence of second neoplasm in childhood cancer survivors treated with GH: an analysis of GeNeSIS and HypoCCS", Eur J Endocrinol, 168, pp.565~573 (2013)